JAGUAR HEALTH INC (JAGX)
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
$0.41-18.38%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
QuarterlyIQ Insights · JAGX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and operates in a high-miss-rate industry. A fundamental tilt, not a price call.
Model as of 2026-11-05 · Compared with 117 industry peers
JAGX — dividend update
Dated 2026-11-03
Other Events. As previously disclosed, on October 15, 2026, Jaguar Health, Inc. (the “Company” or “Jaguar”) paid a special one time dividend of one share of Series R Convertible Preferred Stock, par value $0.0001 per share (the “Series O Preferred Stock”) for each share of voting common stock, par value $0.0001 per share, of the Company (the “Common Stock”) outstanding, plus each share issuable upon exercise of certain warrants and pre-funded warrants to purchase, in aggregate, up to 142,535…
Why it matters: A complete package by year-end keeps Jaguar on its stated path to file an NDA in Q2 2027.
Supportive ifJaguar says the MVID clinical package is ready by December 31, 2026, and still targets an NDA filing in Q2 2027.
Worry ifJaguar says the package is incomplete after year-end or delays the planned Q2 2027 filing.
Why it matters: Jaguar secured a $40 million equity line, but it is still loss-making. Its use may affect the share count.
Worry ifA filing shows equity-line draws that issue new shares while cash use remains high or net losses persist.
Less concerning ifJaguar reports no equity-line draws and lower operating losses. Or it funds its needs without new shares.
Why it matters: Jaguar regained Nasdaq's minimum bid-price compliance in May. Losing it again could put its listing at risk.
Worry ifNasdaq confirms Jaguar remains in compliance with the bid-price rule in a future notice.
Less concerning ifNasdaq sends Jaguar a new bid-price deficiency notice.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$645 on $10,000 · ±6.5% | How much price usually moves either way. |
| Bad day | $2,422 loss on $10,000 · 24.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,996 loss on $10,000 · 100.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.